INDIGO Biosciences Welcomes New Member to Board of Directors

STATE COLLEGE, Pa. (PRWEB) August 13, 2019 INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment of Mark McLoughlin to the Company’s Board of Directors. Mark brings four decades of healthcare…

Source link

Related posts

Honey bee caste lipidomics in relation to life-history stage and the long life of the queen [RESEARCH ARTICLE]


Going with the Flow: Multiscale Insights into the Composite Nature of Water Transport in Roots


BMC enters the world of chemical engineering


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy